A multidisciplinary team has uncovered a key mechanism that allows the human bacterium Mycoplasma pneumoniae—responsible for ...
A generally healthy 63-year-old man in the New England area went to the hospital with a fever, cough, and vision problems in ...
The company recently hit significant roadblocks with its BTK inhibitor, but there are plenty of fish in the sea for the drug ...
AZoLifeSciences on MSN
Bacteria Target Fat-Rich Tissues for Essential Lipids
A multidisciplinary team co-led by the UAB has uncovered a key mechanism that allows the human bacterium Mycoplasma pneumoniae—responsible for ...
News-Medical.Net on MSN
Researchers discover how Mycoplasma pneumoniae acquires cholesterol from human hosts
A multidisciplinary team has uncovered a key mechanism that allows the human bacterium Mycoplasma pneumoniae-responsible for atypical pneumonia and other respiratory infections-to obtain cholesterol ...
Mirum Pharmaceuticals, Inc. , a leading rare disease company, today provided its preliminary and unaudited estimates for full-year 2025 net product sales, year-end cash balance, corporate updates and ...
2026 is shaping up to be a pivotal year for rare disease drugmakers, with key approvals, filings and readouts lined up for ...
GB News on MSN
Pancreatic cancer warning as woman says her stage 4 symptoms were triggered by eating 'anything'
A woman has shared the troubling symptoms she experienced over the course of a year before receiving a devastating stage 4 ...
Detailed price information for Replimune Group Inc (REPL-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback